Method of packing polynucleotides

US10793889B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10793889-B2
Application numberUS-201715444605-A
CountryUS
Kind codeB2
Filing dateFeb 28, 2017
Priority dateOct 13, 2016
Publication dateOct 6, 2020
Grant dateOct 6, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a method of preparing nanoparticle-type polynucleotides, the method comprising forming the polynucleotides comprising modified nucleotides, in which the forming includes chemically synthesizing the polynucleotides comprising modified nucleotides, synthesizing the polynucleotides comprising modified nucleotides using an enzyme, or a combination thereof.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of preparing nanoparticle polynucleotides, the method comprising forming the polynucleotides comprising modified nucleotides, wherein the forming comprises chemically synthesizing the polynucleotides comprising modified nucleotides, synthesizing the polynucleotides comprising modified nucleotides using an enzyme, or a combination thereof, and wherein the polynucleotides comprise at least partially a nucleotide sequence forming a secondary structure, a tertiary structure, a quaternary structure, or a combination thereof as a biomolecular structure, wherein the modified nucleotides have a modification of the hydrogen of the 8-carbon site of the purine ring when a base of the modified nucleotides is adenine or guanine, of the hydrogen of the 5-carbon site of the pyrimidine ring when a base of the modified nucleotides is cytosine or uracil, and of the methyl group of the 5-carbon site of the pyrimidine ring when a base of the modified nucleotides is thymine, the modified nucleotides being modified by substituting the hydrogen or the methyl group with a cationic residue. 2. The method of claim 1 , wherein the nanoparticle polynucleotides are self-assembled. 3. The method of claim 1 , wherein the chemically synthesizing the polynucleotides comprising modified nucleotides comprises synthesizing by oligo nucleotides synthesis. 4. The method of claim 1 , wherein the synthesizing the polynucleotides comprising modified nucleotides using an enzyme comprises the steps of extending a primer by incubating a reaction mixture comprising a template nucleotide, a polymerase, modified-NTPs (nucleoside triphosphates), and the primer having a sequence at least partially complementary to the template; and amplifying polynucleotides at least partially comprising the modified nucleotides, wherein the modified-NTPs are one or more selected from the group consisting of modified-ATP, modified-TTP, modified-CTP, modified-GTP, and modified-UTP. 5. The method of claim 4 , wherein the modified-NTPs are dNTPs (deoxyribonucleoside triphosphates) or rNTPs (ribonucleoside triphosphates). 6. The method of claim 4 , wherein the template nucleotide is DNA or RNA. 7. The method of claim 4 , wherein the template nucleotide is single-stranded or double-stranded. 8. The method of claim 4 , wherein the template nucleotide is circular or linear. 9. The method of claim 1 , wherein the modified nucleotides have a modification of one or more of a five-carbon sugar, a phosphate group, and a base. 10. The method of claim 1 , wherein the cationic residue is a substituted C 1 -C 30 alkyl group, a substituted C 2 -C 30 alkenyl group, a substituted C 2 -C 30 alkynyl group, a substituted C 3 -C 30 cycloalkyl group, a substituted C 5 -C 30 aryl group, a substituted C 5 -C 30 arylalkyl group, a substituted C 5 -C 30 arylalkenyl group, a substituted C 5 -C 30 arylalkynyl group, a substituted C 5 -C 30 heteroaryl group, a substituted C 3 -C 30 heterocyclyl group, a substituted C 3 -C 30 heterocycloalkyl group, a substituted C 3 -C 30 heterocyclylalkyl group, a substituted C 5 -C 30 heteroarylalkyl group, a substituted C 5 -C 30 heteroarylalkenyl group, or a substituted C 5 -C 30 heteroarylalkynyl group, which is substituted with one or more selected from the group consisting of an amine, guanidine, pyridine, and imidazole. 11. The method of claim 1 , wherein the modified nucleotides are derived from nucleotides which have any one chemical formula of the following Formulae 4 or 6: 12. The method of claim 1 , wherein the polynucleotides are selected from the group consisting of genomic DNA, antisense oligonucleotides, mRNA, siRNA, micro RNA, sgRNA, and aptamers. 13. The method of claim 1 , wherein the method is used for controlling a surface area of the polynucleotides, used for storing the polynucleotides, or used for controlling transfection of the polynucleotides in cells, wherein controlling the surface area of the polynucleotides is carried out by interacting between nucleotide sequences caused by modified-NTPs, storing the polynucleotides is carried out for long-term storage, and controlling transfection of the polynucleotides is carried out by passing the polynucleotides through cell membrane into cells without transfection reagents.

Assignees

Inventors

Classifications

  • C12Q1/6844Primary

    Nucleic acid amplification reactions · CPC title

  • Allyl · CPC title

  • Rolling circle · CPC title

  • of the base · CPC title

  • Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10793889B2 cover?
Provided is a method of preparing nanoparticle-type polynucleotides, the method comprising forming the polynucleotides comprising modified nucleotides, in which the forming includes chemically synthesizing the polynucleotides comprising modified nucleotides, synthesizing the polynucleotides comprising modified nucleotides using an enzyme, or a combination thereof.
Who is the assignee on this patent?
Korea Inst Sci & Tech
What technology area does this patent fall under?
Primary CPC classification C12Q1/6844. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).